Apotex Well being Company, certainly one of Canada’s largest pharmaceutical corporations, is getting ready to listing on the Toronto Inventory Change in an preliminary public providing that might elevate as much as C$1.2 billion. The corporate filed a preliminary prospectus on Could 28, 2026 underneath the ticker APTX.
What’s the supply?
An IPO consists of a mixture of newly issued treasury and secondary shares. The secondary part primarily comes from controlling shareholder SK Capital Companions, which is seeking to monetize a few of its stake.
The estimated measurement of the providing ranges from C$750 million to C$1 billion, with a possible cap of C$1.2 billion relying on demand.
Apotex’s monetary place gives important help for itemizing. The corporate reported income of C$3.5 billion and revenue of C$374 million.
Apotex has constructed its enterprise across the generic drug market and has a big workforce with operations within the Americas and India.
Strategic background and up to date developments
In April 2026, the corporate entered right into a partnership with Cumberland Prescribed drugs to develop its specialty drug portfolio within the US market.
SK Capital Companions, the personal fairness agency that manages Apotex, is utilizing the IPO as a part of its liquidity occasion. The inclusion of secondary shares within the providing implies that a portion of the proceeds might be paid on to present shareholders, relatively than going into the corporate’s coffers.
What this implies for traders
The valuation calculation begins with gross sales of CA$3.5 billion and earnings of CA$374 million. Comparable generic drug corporations are inclined to commerce at modest earnings multiples in comparison with the broader pharmaceutical sector.
The partnership with Cumberland Prescribed drugs provides a difficulty price monitoring. If Apotex is ready to efficiently construct a specialty drug presence within the US, the expansion story will change dramatically as specialty medication can command increased margins and a extra steady income stream.
